NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $850,140 | -61.7% | 794,523 | -7.2% | 0.00% | – |
| Q2 2023 | $2,218,506 | -26.5% | 856,566 | +15.9% | 0.00% | – |
| Q1 2023 | $3,016,556 | -57.4% | 739,352 | -47.5% | 0.00% | – |
| Q4 2022 | $7,073,692 | -36.8% | 1,409,102 | +64.7% | 0.00% | -100.0% |
| Q3 2022 | $11,191,000 | +13.3% | 855,575 | +11.0% | 0.00% | 0.0% |
| Q2 2022 | $9,877,000 | -6.3% | 770,442 | +11.4% | 0.00% | 0.0% |
| Q1 2022 | $10,545,000 | -11.8% | 691,506 | +2.4% | 0.00% | 0.0% |
| Q4 2021 | $11,961,000 | -8.4% | 675,380 | +8.7% | 0.00% | 0.0% |
| Q3 2021 | $13,057,000 | +11.4% | 621,163 | +4.5% | 0.00% | 0.0% |
| Q2 2021 | $11,726,000 | -17.3% | 594,618 | +21.9% | 0.00% | 0.0% |
| Q1 2021 | $14,177,000 | +0.6% | 487,682 | +4.8% | 0.00% | 0.0% |
| Q4 2020 | $14,093,000 | +100.6% | 465,203 | +5.3% | 0.00% | – |
| Q3 2020 | $7,027,000 | -23.4% | 441,700 | -4.9% | 0.00% | -100.0% |
| Q2 2020 | $9,172,000 | +62.0% | 464,626 | +1.2% | 0.00% | – |
| Q1 2020 | $5,660,000 | -18.7% | 459,052 | +21.9% | 0.00% | – |
| Q4 2019 | $6,965,000 | +287.4% | 376,673 | +190.2% | 0.00% | – |
| Q3 2019 | $1,798,000 | +145.6% | 129,820 | +45.7% | 0.00% | – |
| Q2 2019 | $732,000 | – | 89,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 15,396,116 | $303,611,000 | 42.97% |
| Ponoi II Management, LLC | 1,298,908 | $25,614,000 | 20.76% |
| Ponoi Management, LLC | 1,298,908 | $25,614,000 | 14.23% |
| Euclidean Capital LLC | 1,493,349 | $29,449,000 | 9.56% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $74,279,000 | 6.80% |
| Aquilo Capital Management, LLC | 1,194,237 | $23,550,000 | 6.12% |
| Greenspring Associates, LLC | 1,573,357 | $31,027,000 | 2.10% |
| Octagon Capital Advisors LP | 200,000 | $3,944,000 | 0.82% |
| Redmile Group, LLC | 2,792,448 | $55,067,000 | 0.82% |
| BVF INC/IL | 955,000 | $18,833,000 | 0.71% |